Quantitative analysis of EZH2 expression and its correlations with lung cancer patients’ clinical pathological characteristics

Enhancer of Zeste Homologue 2 Expression in Breast Carcinoma Smears in Relationship with p53, Ki-67 and Other Prognostic Parameters

(2011) Anna Maria Athanassiadou et al.   ACTA CYTOLOGICA

The role of EZH2 in tumour progression

(2011) C-J Chang et al.   BRITISH JOURNAL OF CANCER

Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer

(2011) Huqun et al.   CANCER

EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling

(2011) Chun-Ju Chang et al.   CANCER CELL

High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not

(2011) Jennifer J. Findeis-Hosey et al.   HUMAN PATHOLOGY

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma

(2011) Cheng Wang et al.   MOLECULAR CARCINOGENESIS

p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor

(2011) B Testoni et al.   ONCOGENE

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder

(2011) Hang Wang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer

(2010) JUNG HYE CHOI et al.   APMIS

Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance

(2010) Junko Kikuchi et al.   CANCER

HDAC inhibitors conquer polycomb proteins

(2010) Paul Yaswen   CELL CYCLE

EZH2 silencing by RNA interference inhibits proliferation in bladder cancer cell lines

(2010) Y.B. ZHANG et al.   EUROPEAN JOURNAL OF CANCER CARE

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells

(2009) Xiaojing Yang et al.   PLoS One

Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms

(2008) Raphael Margueron et al.   MOLECULAR CELL

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

(2008) Yutaka Kondo et al.   NATURE GENETICS

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

(2008) Q Cao et al.   ONCOGENE